From Name:
From Email:
To Name:
To Email:

Optional Message:

Quadruple HCV therapy effective for nonresponders

from The Clinical Advisor

Two direct-acting antivirals against hepatitis C virus (HCV) currently in development improved virologic responses among patients with HCV when administered alone or in combination with pegylated interferon-alpha-2a (pegIFN-alpha-2a) and ribavirin, phase-2 trial results indicate. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063